Mitazalimab (Anti-TNFRSF5 / CD40)

Synonyms: ADC-1013; JNJ-64457107

Mitazalimab (Anti-TNFRSF5 / CD40) a human agonist IgG1 antibody targeting CD40. It enhances the anti-tumor efficacy of a model cancer vaccine. MW :143.44 KD.

Mitazalimab (Anti-TNFRSF5 / CD40)

Purity & Quality Control

Choose Selective CD markers Inhibitors

Name Citation CD38 CD45 CD39 CD88 CD73 Others
RBN013209 0
MK-0159 0
CD38 inhibitor 1 (compound 78c) 5
AB680 0
NQ301 1 TXA2 receptor
SodiuM Metatungstate 3
PMX-53
LY-3475070
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Mitazalimab (Anti-TNFRSF5 / CD40) a human agonist IgG1 antibody targeting CD40. It enhances the anti-tumor efficacy of a model cancer vaccine. MW :143.44 KD.

Product Details

CAS No. 2055640-86-1
Isotype Human IgG1
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Mitazalimab (Anti-TNFRSF5 / CD40) | Mitazalimab (Anti-TNFRSF5 / CD40) supplier | purchase Mitazalimab (Anti-TNFRSF5 / CD40) | Mitazalimab (Anti-TNFRSF5 / CD40) cost | Mitazalimab (Anti-TNFRSF5 / CD40) manufacturer | order Mitazalimab (Anti-TNFRSF5 / CD40) | Mitazalimab (Anti-TNFRSF5 / CD40) distributor